12 months ago IMU had with HER-Vaxx a fantastic ph1 result, despite chemo all patient produced antibodies as designed, 100% safe, top doses huge tumor reduction and yet got hammered down. People expect a 100% instant cure, that's the problem. Correct, current t-cell drugs achieve billions of dollars despite small % success and often huge side effects. The anns is great but market doesn't understand, like IMU.
New trial with higher dose will take time and even if sponsored, market won't wait another year for improved results - that's the sad reality. No idea at what sp level it will close today, could be back in 9s or getting smashed into 7s.
In the US, encouraging means fantastic, in AUS it means crap. IMU and the sh had to learn that the hard way.
I am out for time being, actually surprised it went to mid 9s as there were too many words that are interpreted negatively by those who got no idea that just stopping the cancer progressing is success.
GLTA
- Forums
- ASX - By Stock
- PTX
- Ann: Encouraging data from PTX-200 ovarian cancer trial
Ann: Encouraging data from PTX-200 ovarian cancer trial, page-79
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.23M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.3¢ | $36.04K | 810.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.044 |
1 | 330000 | 0.043 |
3 | 246000 | 0.041 |
7 | 925642 | 0.040 |
3 | 95000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 974 | 1 |
0.047 | 63339 | 2 |
0.049 | 114091 | 2 |
0.050 | 236935 | 5 |
0.051 | 19607 | 1 |
Last trade - 13.57pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
PTX (ASX) Chart |